Skip to main content
Top
Published in: Supportive Care in Cancer 5/2011

01-05-2011 | Original Article

Breast cancer treatment-related lymphedema self-care: Education, practices, symptoms, and quality of life

Authors: Sheila H. Ridner, Mary S. Dietrich, Nancy Kidd

Published in: Supportive Care in Cancer | Issue 5/2011

Login to get access

Abstract

Purpose

The primary purpose of this study was to cross-sectionally examine breast cancer treatment-related lymphedema self-care education, self-care practices, and perceived self-care barriers, burdens, and benefits. We also explored the associations among self-care education, practices, symptoms, and quality of life (QOL) in breast cancer survivors with known lymphedema.

Methods

A cross-sectional design was used to obtain data about lymphedema self-care education, self-care practices, perceived self-care barriers, burdens, and benefits, symptoms, and QOL. Frequency distributions and Spearman rank-order correlations were used to analyze quantitative data. Thematic qualitative analysis of perceived barriers, benefits, and burdens of self-care was also undertaken.

Results

Surveys were completed and returned by 51 of 58 eligible individuals. Of the 51 responding, 48 had received some self-care education, but three did not think it was adequate. Wearing a compression garment was the most frequently cited self-care activity, and 18 of the 51 required help with self-care. Thirty-three percent, 17/51, spent 15 minutes or less per day on self-care. Multiple barriers to self-care were identified. Those with more symptoms spent more time on self-care activities and had a poorer QOL.

Conclusions

Opportunities exist to improve lymphedema self-care education. Breast cancer survivors with lymphedema experience symptoms beyond that of simple swelling of the affected limb. Self-care is burdensome. Barriers to providing lymphedema self-care exist and may vary across patients. A multidisciplinary approach to lymphedema management, including self-care education and monitoring, is likely needed to improve QOL in this population.
Literature
1.
go back to reference Coward DD (1999) Lymphedema prevention and management knowledge in women treated for breast cancer. Oncol Nurs Forum 26:1047–1053PubMed Coward DD (1999) Lymphedema prevention and management knowledge in women treated for breast cancer. Oncol Nurs Forum 26:1047–1053PubMed
2.
go back to reference Curran SL, Andrykowski MA, Studts JL (1995) Short form of the Profile of Mood States (POMS-SF): psychometric information. Psychol Assess 7:80–82CrossRef Curran SL, Andrykowski MA, Studts JL (1995) Short form of the Profile of Mood States (POMS-SF): psychometric information. Psychol Assess 7:80–82CrossRef
4.
go back to reference Garfield FB, Caro JJ (1996) Compliance and hypertension. Curr Hypertens Rep 1:502–506CrossRef Garfield FB, Caro JJ (1996) Compliance and hypertension. Curr Hypertens Rep 1:502–506CrossRef
5.
go back to reference International Society of Lymphology (2003) The diagnosis and treatment of peripheral lymphedema: consensus document of the International Society of Lymphology. Lymphology 36:84–91 International Society of Lymphology (2003) The diagnosis and treatment of peripheral lymphedema: consensus document of the International Society of Lymphology. Lymphology 36:84–91
7.
go back to reference Jerant AF, Friederichs-Fitzwater MM, Moore M (2005) Patients' perceived barriers to active self-management of chronic conditions. Patient Educ Couns 57:300–307, 10.1016/j.pec.2004.08.004PubMedCrossRef Jerant AF, Friederichs-Fitzwater MM, Moore M (2005) Patients' perceived barriers to active self-management of chronic conditions. Patient Educ Couns 57:300–307, 10.1016/j.pec.2004.08.004PubMedCrossRef
9.
go back to reference Kaviani A, Fateh M, Nooraie RY, Alinagi-zadeh M, Ataie-Fashtami L (2006) Low-level laser therapy in management of postmastectomy lymphedema. Lasers Med Sci 21:90–94PubMedCrossRef Kaviani A, Fateh M, Nooraie RY, Alinagi-zadeh M, Ataie-Fashtami L (2006) Low-level laser therapy in management of postmastectomy lymphedema. Lasers Med Sci 21:90–94PubMedCrossRef
10.
go back to reference Launois R, Alliot F (2000) Quality of life scale in upper limb lymphedema—a validation study. Lymphology 33:266–270 Launois R, Alliot F (2000) Quality of life scale in upper limb lymphedema—a validation study. Lymphology 33:266–270
11.
go back to reference Lewis M, Morgan K (2008) Managing chronic oedema: a collaborative community approach. Br J Community Nurs 13:S25–26, S28–32 Lewis M, Morgan K (2008) Managing chronic oedema: a collaborative community approach. Br J Community Nurs 13:S25–26, S28–32
12.
go back to reference Framework L (2006) Best practice for the management of lymphoedema: international consensus. MEP Ltd, London Framework L (2006) Best practice for the management of lymphoedema: international consensus. MEP Ltd, London
13.
go back to reference McNair PM, Lorr M, Droppleman L (1981) POMS manual. Educational and industrial testing service, San Diego, CA McNair PM, Lorr M, Droppleman L (1981) POMS manual. Educational and industrial testing service, San Diego, CA
17.
go back to reference Ridner SH (2004) Symptoms clusters occurring with lymphedema after breast cancer. Dissertation Abstracts International 61,11 (UMI No. 3113289). Ridner SH (2004) Symptoms clusters occurring with lymphedema after breast cancer. Dissertation Abstracts International 61,11 (UMI No. 3113289).
18.
go back to reference Ridner SH (2006) Pretreatment lymphedema education and identified educational resources in breast cancer patients. Patient Educ Couns 61:72–79PubMedCrossRef Ridner SH (2006) Pretreatment lymphedema education and identified educational resources in breast cancer patients. Patient Educ Couns 61:72–79PubMedCrossRef
21.
22.
go back to reference Shih YCT, Xu Y, Cormier JN, Giordano S, Ridner SH, Buchholz TA, Perkins GH, Elting LS (2009) Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 27:2007–2014. doi:10.1200/JCO.2008.18.3517 PubMedCrossRef Shih YCT, Xu Y, Cormier JN, Giordano S, Ridner SH, Buchholz TA, Perkins GH, Elting LS (2009) Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 27:2007–2014. doi:10.​1200/​JCO.​2008.​18.​3517 PubMedCrossRef
23.
go back to reference Sneddon M, Lewis M (2006) Lymphoedema: a female health issue with implications for self care. Br J Nurs 16:76 Sneddon M, Lewis M (2006) Lymphoedema: a female health issue with implications for self care. Br J Nurs 16:76
25.
go back to reference Weissleder H, Schuchhardt C (2001) Lymphedema: diagnosis and therapy. Viavital Verlag, Koln, Germany Weissleder H, Schuchhardt C (2001) Lymphedema: diagnosis and therapy. Viavital Verlag, Koln, Germany
26.
go back to reference Willis JW (2007) Foundations of qualitative research: interpretive and critical approaches. Sage Publications, Inc., Thousand Oaks, CA Willis JW (2007) Foundations of qualitative research: interpretive and critical approaches. Sage Publications, Inc., Thousand Oaks, CA
Metadata
Title
Breast cancer treatment-related lymphedema self-care: Education, practices, symptoms, and quality of life
Authors
Sheila H. Ridner
Mary S. Dietrich
Nancy Kidd
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 5/2011
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-010-0870-5

Other articles of this Issue 5/2011

Supportive Care in Cancer 5/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine